M08.921
Juvenile arthritis, unspecified, right elbow
Clinical Classification Guidelines
Medical Intelligence & Overview
Juvenile arthritis, also known as juvenile idiopathic arthritis (JIA), is a chronic autoimmune condition that affects children and adolescents. Specifically, code M08.921 pertains to cases where the arthritis is localized to the right elbow without a more specific classification. This condition causes inflammation, pain, and swelling in the affected joint, which can impact a child's daily activities and overall well-being. Though the exact cause is unknown, juvenile arthritis involves the immune system mistakenly attacking healthy joint tissues, leading to inflammation and joint damage.
Causes & Symptoms
Clinical Causes: Genetic predisposition, where inherited genes may increase risk Autoimmune response, where the body's immune system erroneously targets joint tissues Environmental factors, such as infections or exposure to certain environmental agents that could trigger the immune response Hormonal influences possibly affecting disease development Other factors that are not fully understood but may contribute to the onset of juvenile arthritis
Key Symptoms: Persistent joint swelling in the right elbow Pain or tenderness around the joint Stiffness, especially after periods of rest or in the mornings Limited range of motion in the affected elbow Warmth or redness around the joint Occasional fever and fatigue in some cases General discomfort or irritability seen in some children
Diagnostic & Treatment
Diagnosis Path: Blood tests to identify inflammation markers or autoimmune antibodies X-rays or MRI scans to visualize joint damage or inflammation Arthrocentesis, where a small sample of joint fluid is collected for analysis Assessment of other joints to determine the extent or distribution of the disease
Treatment Protocols: Nonsteroidal anti-inflammatory drugs (NSAIDs) to relieve pain and decrease inflammation Physical and occupational therapy to maintain joint function and improve mobility Disease-modifying antirheumatic drugs (DMARDs) like methotrexate to slow disease progression Biologic agents targeting specific immune pathways in severe cases Regular monitoring and follow-up to adjust treatments as needed Lifestyle modifications, including a balanced diet and appropriate exercise, to support overall health and joint function
Clinical Advice & FAQs
Billing Guidance
Is M08.921 a billable ICD-10 code?
Yes, M08.921 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M08.921?
Clinical documentation must specify the nature of Juvenile arthritis, unspecified, right elbow and any associated comorbidities for accurate reporting.
Cite this Clinical Reference